Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bal Pharma Ltd 2 ...more...
As per the provisions of Regulation 31A of SEBI(LODR) Regulations we are herewith withdrawing our application for reclassification of promoters.more...
Bal Pharma Limited has informed the Exchange about update on its application for reclassification of promoters.more...
Shailesh Siroya For and on behalf of Promoter and Promoter Group of the Company has Submitted to the Exchange a copy of Disclosure under Reg...more...
As of March 2025 50.86% is owned by Promoters and 49.14% by Public. Among Promoters holding Indian Promoters holds 46.75% and Foreign Promoters holds...more...
Certificate in compliance with SEBI(PIT)Regulations 2015.more...
Bal Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
We are submitting the certificate in compliance with Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2025.more...
Bal Pharma Limited has informed the Exchange about NCLT order on Scheme of Arrangement/merger of Golden Drugs Pvt Ltd ( Transferer Company ) with Bal...more...
Hon ble NCLT Bangalore bench has approved the scheme of arrangement between Golden Drugs Pvt Ltd ( Transferer Company) a wholly owned subsid...more...
BAL PHARMA LIMITED has informed the Exchange about Closure of Trading Windowmore...
Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Withdrawal of reclassification application made with the exchanges as per the provisions of Regulation 31A of SEBI(LODR) Regulations 2015.more...
Bal Pharma Limited has informed the Exchange about withdrawal of its application for reclassification of promoters.more...
Bal Pharma Limited has informed the Exchange regarding Update s on Unaudited Financial Results-31.12.2024.more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results for the quarter ended 31.12.2024.more...
Integrated Filings ( Financial ) for the quarter ended 31.12.2024.more...
We are submitting to the exchange integrated filing ( Finance) for the quarter ended 31.12.2024.more...
The company reported standalone net profit of Rs 1.16 crore for the quarter ended December 31 2024 as compared to Rs 1.26 crore in the same period la...more...
The Board of Directors at their meeting held on 13.02.2025 has taken on record and approved Un audited financial results of the Company for ...more...
Enter Stock
BOARD MEETINGS Company Name : Aadhar Housing Fin Date : 06-05-2025